NCT06709079View on ClinicalTrials.gov

Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Allergic Rhinitis
Interventions
DRUG

Aescine Sodium Tablets (Ocai®, Green Leaf Pharmaceuticals)

Preoperatively, patients with AR were given 2 tablets of Aescine Sodium Tablets (Ocai®, Green Leaf Pharmaceuticals) to be taken after meals, once in the morning and once in the evening, for a period of 20 days.

Trial Locations (1)

Unknown

The First Affiliated Hospital with Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Cheng Lei

OTHER

NCT06709079 - Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis | Biotech Hunter | Biotech Hunter